Synthesis, characterization, and evaluation of a novel 99mTc(CO)3 pyrazolyl conjugate of a peptide nucleic acid sequence.
The 16-mer peptide nucleic acid sequence H-A GAT CAT GCC CGG CAT-Lys-NH2 (1), which is complementary to the translation start region of the N-myc oncogene messenger RNA, was synthesized and conjugated to a pyrazolyl diamine bifunctional chelator (pz). The novel conjugate pz-A GAT CAT GCC CGG CAT-Lys-NH2 (2) was labeled with technetium tricarbonyl, yielding quantitatively the complex fac-[99mTc(CO)3(kappa3-pz-A GAT CAT GCC CGG CAT-Lys-NH2)]2+ (4). Complex 4 was obtained with high radiochemical purity and high specific activity, revealing high stability in human serum and in cell culture medium. The identity of 4 was confirmed by comparing its reversed-phase high performance liquid chromatography profile with that of the rhenium analog fac-[Re(CO)3(kappa3-pz-A GAT CAT GCC CGG CAT-Lys-NH2)]2+ (3), prepared by conjugation of fac-[Re(CO)3(3,5-Me2pz(CH2)2N((CH2)3COOH)(CH2)2NH2)]+ to 1, using solid-phase techniques. UV melting experiments of 1 and 3 with the complementary DNA sequence led to the formation of stable duplexes, indicating that the conjugation of 1 to the pyrazolyl chelator and to the metal fragment fac-[M(CO)3]+ did not affect the recognition of the complementary sequence as well as the duplex stability. For a first screening, SH-SY5Y human neuroblastoma cells, which express N-myc, were treated with 4. The results show that 4 internalizes (7% of the activity goes into the cells, after 4 h at 37 degrees C), presenting also a relatively high cellular retention (only 40% of internalized activity is released from the cells after 5 h).
Xavier
Catarina
C
Unidade de Ciências Químicas e Radiofarmacêuticas, Instituto Tecnológico e Nuclear, Estrada Nacional 10, 2686-953, Sacavém, Portugal.
Giannini
Clelia
C
Dall'Angelo
Sergio
S
Gano
Lurdes
L
Maiorana
Stefano
S
Alberto
Roger
R
Santos
Isabel
I
D001483:Base Sequence; D045744:Cell Line, Tumor; D002614:Chelating Agents / Q000737:chemistry; D002851:Chromatography, High Pressure Liquid; D003959:Diamines / Q000737:chemistry; D006801:Humans; D008956:Models, Chemical; D015336:Molecular Probe Techniques; D015335:Molecular Probes / Q000138:chemical synthesis* / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology; D015609:Organotechnetium Compounds / Q000138:chemical synthesis* / Q000737:chemistry; D020135:Peptide Nucleic Acids / Q000737:chemistry* / Q000235:genetics; D011720:Pyrazoles / Q000737:chemistry*; D013667:Technetium / Q000737:chemistry*; D013696:Temperature; D013997:Time Factors
D002614:Chelating Agents; D003959:Diamines; D015335:Molecular Probes; D015609:Organotechnetium Compounds; D020135:Peptide Nucleic Acids; D011720:Pyrazoles; D013667:Technetium
Science. 1991 Dec 6;254(5037):1497-500
1962210
Bioconjug Chem. 2005 Mar-Apr;16(2):294-305
15769082
J Nucl Med. 2006 Oct;47(10):1670-7
17015904
World J Surg. 2005 Mar;29(3):281-6
15706438
Semin Nucl Med. 2007 Jul;37(4):286-302
17544628
Bioconjug Chem. 2005 Mar-Apr;16(2):438-49
15769099
Neurosci Lett. 2003 Jan 9;336(1):55-9
12493601
Bioconjug Chem. 2005 Jan-Feb;16(1):70-9
15656577
Biopolymers. 2004;76(4):324-33
15386267
Nucleosides Nucleotides Nucleic Acids. 2005;24(5-7):409-14
16247960
Science. 2003 Oct 24;302(5645):605-8
14576425
Bioconjug Chem. 1999 Nov-Dec;10(6):965-72
10563765
Cancer. 1997 Dec 15;80(12 Suppl):2699-705
9406727
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1772-6
2869488
Nature. 1993 Oct 7;365(6446):566-8
7692304
Mol Cancer Ther. 2005 May;4(5):779-86
15897242
J Nucl Med. 2007 Oct;48(10):1699-707
17909257
Nucl Med Biol. 2006 Jul;33(5):625-34
16843837
Biochem Pharmacol. 1994 Sep 15;48(6):1310-3
7945427
J Nucl Med. 2004 Dec;45(12):2070-82
15585484
J Biol Chem. 2004 Jul 2;279(27):27994-9
15117961
Proc Natl Acad Sci U S A. 2002 May 14;99(10):7021-6
12011461
J Nucl Med. 1997 Jun;38(6):907-13
9189140
FASEB J. 2000 Jun;14(9):1041-60
10834926
Bioconjug Chem. 1997 Jul-Aug;8(4):481-8
9258444
Cancer. 1990 Nov 15;66(10):2053-8
2171744
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12021-6
14512516
Bioconjug Chem. 2001 Sep-Oct;12(5):807-16
11562199
Bioconjug Chem. 2003 Nov-Dec;14(6):1083-95
14624621
Bioconjug Chem. 2007 Mar-Apr;18(2):530-7
17373771
J Biol Inorg Chem. 2008 Mar;13(3):449-59
18183429
Nucl Med Biol. 2005 Jan;32(1):1-20
15691657
Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1529-42
12397472
Peptides. 2002 Sep;23(9):1557-65
12217415
Biochem Pharmacol. 1997 May 15;53(10):1465-76
9260874
Nucl Med Commun. 2003 Aug;24(8):857-63
12869817
Curr Top Med Chem. 2007;7(7):681-94
17430209
Proc Natl Acad Sci U S A. 1986 Feb;83(4):1092-6
2869482
Bioconjug Chem. 2000 Nov-Dec;11(6):741-3
11087319
Nat Struct Biol. 1997 Feb;4(2):98-101
9033585
Int J Oncol. 2004 Feb;24(2):265-72
14719101
J Cell Biochem. 2003 Oct 15;90(3):464-72
14523980
J Biol Chem. 1996 Dec 27;271(52):33580-6
8969225